These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


856 related items for PubMed ID: 22668640

  • 41. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
    Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS.
    J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517
    [Abstract] [Full Text] [Related]

  • 42. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ, Cheng CC, Chou SM, Hor CB, Yang YC, Wang HL.
    Vaccine; 2009 Nov 05; 27(47):6613-8. PubMed ID: 19698812
    [Abstract] [Full Text] [Related]

  • 43. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M.
    Haematologica; 2007 Dec 05; 92(12):1664-70. PubMed ID: 18055990
    [Abstract] [Full Text] [Related]

  • 44. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
    Alizadeh Z, Milani S, Sharifi Z.
    Arch Iran Med; 2014 Feb 05; 17(2):106-7. PubMed ID: 24527970
    [Abstract] [Full Text] [Related]

  • 45. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan 05; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 46. Stable seroepidemiology of hepatitis B after universal immunization in Taiwan: A 3-year study of national surveillance of primary school students.
    Chen CY, Hsu HY, Liu CC, Chang MH, Ni YH.
    Vaccine; 2010 Aug 02; 28(34):5605-8. PubMed ID: 20598405
    [Abstract] [Full Text] [Related]

  • 47. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH, Chen CH, Wang JH, Lee CM, Changchien CS, Lu SN.
    Liver Int; 2005 Dec 02; 25(6):1162-8. PubMed ID: 16343067
    [Abstract] [Full Text] [Related]

  • 48. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC.
    Transfusion; 2007 Oct 02; 47(10):1809-15. PubMed ID: 17880605
    [Abstract] [Full Text] [Related]

  • 49. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization.
    Hipgrave DB, Nguyen TV, Vu MH, Hoang TL, Do TD, Tran NT, Jolley D, Maynard JE, Biggs BA.
    Am J Trop Med Hyg; 2003 Sep 02; 69(3):288-94. PubMed ID: 14628946
    [Abstract] [Full Text] [Related]

  • 50. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination.
    Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS.
    Ann Intern Med; 2001 Nov 06; 135(9):796-800. PubMed ID: 11694104
    [Abstract] [Full Text] [Related]

  • 51. Occult hepatitis B virus and surface antigen mutant infection in healthy vaccinated cohorts and children with various forms of hepatitis and multiple transfusions.
    Hung WL, Wu JF, Ni YH, Chen HL, Chiang CL, Chang MH, Hsu HY.
    Liver Int; 2019 Jun 06; 39(6):1052-1061. PubMed ID: 30790411
    [Abstract] [Full Text] [Related]

  • 52. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ.
    Vaccine; 2001 Jul 16; 19(28-29):3919-26. PubMed ID: 11427266
    [Abstract] [Full Text] [Related]

  • 53. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.
    Biol Blood Marrow Transplant; 2010 Jun 16; 16(6):809-17. PubMed ID: 20060484
    [Abstract] [Full Text] [Related]

  • 54. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
    Altindiş M, Uslan I, Cetinkaya Z, Yüksel S, Ciftçi IH, Demirtürk N, Ozdemir M, Arslan F, Aktepe OC.
    Mikrobiyol Bul; 2007 Apr 16; 41(2):227-33. PubMed ID: 17682709
    [Abstract] [Full Text] [Related]

  • 55. Hepatitis B virus exposure during childhood in Cameroon, Central African Republic and Senegal after the integration of HBV vaccine in the expanded program on immunization.
    Rey-Cuille MA, Njouom R, Bekondi C, Seck A, Gody C, Bata P, Garin B, Maylin S, Chartier L, Simon F, Vray M.
    Pediatr Infect Dis J; 2013 Oct 16; 32(10):1110-5. PubMed ID: 23694839
    [Abstract] [Full Text] [Related]

  • 56. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J, Zhang J, Wu C, Shao X, Peng G, Peng Z, Ma W, Zhang Y, Zheng H.
    Int J Infect Dis; 2012 Sep 16; 16(9):e692-6. PubMed ID: 22795176
    [Abstract] [Full Text] [Related]

  • 57. Seroepidemiology and occult hepatitis B virus infection in young adults in Banjarmasin, Indonesia.
    Darmawan E, Turyadi, El-Khobar KE, Nursanty NK, Thedja MD, Muljono DH.
    J Med Virol; 2015 Feb 16; 87(2):199-207. PubMed ID: 25521058
    [Abstract] [Full Text] [Related]

  • 58. Hepatitis B virus markers among teenagers in the Araguaia region, Central Brazil: assessment of prevalence and vaccination coverage.
    Melo LV, da Silva MA, Calçada Cde O, Cavalcante SR, Souto FJ.
    Vaccine; 2011 Jul 18; 29(32):5290-3. PubMed ID: 21605613
    [Abstract] [Full Text] [Related]

  • 59. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A.
    Int J Infect Dis; 2010 Apr 18; 14(4):e308-10. PubMed ID: 19656713
    [Abstract] [Full Text] [Related]

  • 60. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J, Li RC, Yang JY, Li YP, Chen XR, Xu ZY, Liu CB, Cao HL, Zhao K, Ni DM.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr 18; 11(4):203-5. PubMed ID: 12716514
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 43.